Federation des caisses Desjardins du Quebec »

Transcode Therapeutics shares owned by Federation des caisses Desjardins du Quebec

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Federation des caisses Desjardins du Quebec from 13F filings

Historical chart of Federation des caisses Desjardins du Quebec investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Federation des caisses Desjardins du Quebec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Federation des caisses Desjardins du Quebec

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 975 10.75

More positions owned by Federation des caisses Desjardins du Quebec

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Apple (AAPL)
Bk Nova Cad (BNS)
Cgi Cl A Sub Vtg (GIB)
Amazon (AMZN)
Tc Energy Corp (TRP)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Cibc Cad (CM)
Enbridge (ENB)
Telus Ord (TU)

View all positions for Federation des caisses Desjardins du Quebec

Top funds holding Transcode Therapeutics

DRW Holdings
Federation des caisses Desjardins du Quebec
Tower Research Capital
SBI Securities
Royal Bank of Canada
Advisor Group Holdings

View all funds holding Transcode Therapeutics